NervGen Pharma Corp Closes Non-Brokered Private Placement finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Emgold Mining Corporation: Emgold Announces Flow-Through Private Placement and Closes First Tranche
( Emgold or the Company ) announces it plans to complete a non-brokered flow-through private placement (the
FT Offering ) consisting of up to 12,500,000 units of the Corporation (the
FT Units ) at a price of CDN$0.08 per FT Unit (the
FT Offering Price ) to raise up to CDN$1,000,000. Each FT Unit will consist of one common share in the capital of the Company (a
Common Share ) and one-half of one non-transferable common share purchase warrant (each whole common share purchase warrant, a
Warrant ). Each Warrant will be exercisable to acquire one Common Share of the Corporation at an exercise price of CDN$0.10 per Common Share for a period of 24 months from the date of issuance. The FT Offering is subject to a minimum subscription amount of CDN$3,000.
Emgold Announces Flow-Through Private Placement and Closes First Tranche
ACCESSWIRE
17 Jul 2021, 09:31 GMT+10
VANCOUVER, BBC / ACCESSWIRE / July 16, 2021 / Emgold Mining Corporation (TSXV:EMR)(OTC PINK:EGMCF)(FRA:EMLM)(BSE:EMLM)
( Emgold or the Company ) announces it plans to complete a non-brokered flow-through private placement (the
FT Offering ) consisting of up to 12,500,000 units of the Corporation (the
FT Units ) at a price of CDN$0.08 per FT Unit (the
FT Offering Price ) to raise up to CDN$1,000,000. Each FT Unit will consist of one common share in the capital of the Company (a
Common Share ) and one-half of one non-transferable common share purchase warrant (each whole common share purchase warrant, a
Friday, July 16, 2021 4:20 PM PDT
VANCOUVER, BBC / ACCESSWIRE / July 16, 2021 / Emgold Mining Corporation (TSXV:EMR)(OTC PINK:EGMCF)(FRA:EMLM)(BSE:EMLM)
( Emgold or the Company ) announces it plans to complete a non-brokered flow-through private placement (the
FT Offering ) consisting of up to 12,500,000 units of the Corporation (the
FT Units ) at a price of CDN$0.08 per FT Unit (the
FT Offering Price ) to raise up to CDN$1,000,000. Each FT Unit will consist of one common share in the capital of the Company (a
Common Share ) and one-half of one non-transferable common share purchase warrant (each whole common share purchase warrant, a
Biocure Technology Inc.: BioCure Technology Inc. Announces Closing of Financing
Vancouver, British Columbia (Newsfile Corp. - July 14, 2021) - BioCure Technology Inc. (CSE: CURE) ( BioCure or the Company ) announces that it has successfully closed a non-brokered private placement (the Private Placement ) consisting of 6,706,525 Units at a price of $0.16 cents per Unit for gross proceeds of $1,073,044.00
Each Unit is comprised of one common share (the Shares ) and one share purchase warrant (the Warrants ) of the Company, where each whole Warrant entitles the holder to purchase an additional share for a period of two years from closing, at a price of $0.21 per Warrant share (the Warrant Shares ).